Press Releases

  • Nov. 2021
    Dr. Dirk Winnemöller joins Leukocare as Vice President Commercial
  • Sep. 2021
    Leukocare Strengthens Intellectual Property Portfolio on Virus Formulations in the US
  • Aug. 2021
    Dr. Cornelius Pompe joined Leukocare as Vice President R&D; Dr. Sabine Hauck appointed as Senior Vice President Corporate Development
  • Jul. 2021
    Strong growth: Leukocare moves into new headquarters at the Innovation and Start-up Center for Biotechnology (IZB) in Martinsried/Planegg
  • Jul. 2021
    Auf Wachstumskurs: Leukocare bezieht neuen Firmenstandort am Innovations- und Gründungszentrum Biotechnologie (IZB) in Martinsried/Planegg
  • Jun. 2021
    Leukocare Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities
  • Jun. 2021
    Leukocare gibt Finanzierungsrunde in Höhe von 17,5 Mio. US-Dollar zum weiteren Ausbau des US-Geschäfts und der Bioinformatik-Aktivitäten bekannt
  • May. 2021
    Leukocare cooperates with the Drug Safety Foundation and the Central Laboratory of German Pharmacists to investigate the stability of monoclonal antibodies during shipment and storage
  • May. 2021
    Leukocare appoints Dr. Georg Dönges as Chief Financial Officer
  • Mar. 2021
    Leukocare and Formycon cooperate in the development of high-quality biopharmaceuticals